Skip to main content
. 2015 Jun 15;2015(6):CD007402. doi: 10.1002/14651858.CD007402.pub3

Comparison 6. Topical NSAID versus active comparator.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Clinical success ‐ topical piroxicam vs topical indomethacin 3 641 Risk Ratio (M‐H, Fixed, 95% CI) 1.24 [1.07, 1.44]
2 Local adverse events ‐ topical piroxicam vs topical indomethacin 3 671 Risk Ratio (M‐H, Fixed, 95% CI) 0.21 [0.09, 0.47]